Ziopharm Oncology reported $605K in Trade Creditors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Amgen AMGN:US $ 1403M 37M
Bioline Rx BLRX:US $ 5.78M 0.22M
Corcept Therapeutics CORT:US $ 6.91M 0.35M
Curis CRIS:US $ 4.28M 2.14M
Eleven Biotherapeutics EBIO:US 666K 2.19M
Intrexon XON:US $ 3.62M 1.31M
Novartis NOVN:VX 5.55B 888M
Sangamo Biosciences SGMO:US 11.15M 1.39M
Verastem VSTM:US $ 2.9M 2.26M
Ziopharm Oncology ZIOP:US $ 605K 763K